Production & Manufacturing

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies existing CDO partnership first established in 2018. “As we already have a track record of successful...

Tiziana Life Sciences plc, a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody...

Cytiva, formerly part of GE Healthcare Life Sciences, is celebrating the completion of an extensive renovation to its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, Massachusetts, USA. The upgraded facility is 60,000 square feet (5,600...

Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm,  announced the opening of a new, state-of-the-art manufacturing facility in West Sacramento, California. Gemini...

Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca...

GlaxoSmithKline and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative biopharmaceutical therapies. Under the terms of the agreement, Samsung Biologics will provide GSK with additional capacity for large-scale biopharmaceutical...

Recipharm, a leading contract development and manufacturing organisation (CDMO), has now secured supply of the active pharmaceutical ingredient (API) chloroquine phosphate for its drug Klorokinfosfat RPH Pharma and commenced manufacture of the product. The move comes following reports that chloroquine...